“Is this permanent? Is this the new norm? I want my life back.’’
Nancy Rose, center in mirror, speaks with her mother, Amy Russell, right, who both contracted COVID-19 in 2021, in their dining room surrounded by pictures of relatives and family, Tuesday, Jan. 25, 2022, in Port Jefferson, N.Y. More than a third of COVID-19 survivors by some estimates develop lingering problems.
As these theories and others are tested, there is fresh evidence that vaccination may reduce the chances of developing long COVID. Justyna Fert-Bober and Dr. Susan Cheng were among researchers at Cedars-Sinai Medical Center in Los Angeles who found that some people who have had COVID-19, including cases without symptoms, have a variety of these elevated “autoantibodies" up to six months after recovering. Some are the same ones found in people with autoimmune diseases.
Some of these symptoms may first appear during an initial infection but linger or recur a month or more later. Or new ones may develop, lasting for weeks, months or over a year. Hogan, the New York nurse, also wasn’t hospitalized with COVID-19 but has been debilitated since her diagnosis. Her husband, a disabled veteran, and children ages 9, 13 and 15 fell ill soon after and were sick with fever, stomach pains and weakness for about a month. Then all seemed to get a little better until new symptoms appeared.
Study participant Nancy Rose, 67, of Port Jefferson, New York, said many of her symptoms waned after she got vaccinated, though she still has bouts of fatigue and memory loss.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Russia's daily COVID-19 infections spike above 110,000 as omicron variant impacts countryThe daily count of new coronavirus infections in Russia spiked above 110,000 as the highly contagious omicron variant races impacts the country.
Lire la suite »
What to know about BA.2, the newest COVID-19 omicron variantIt’s called the “stealth” variant, but there’s nothing particularly stealthy about it. Researchers are working to parse whether it is a new threat.
Lire la suite »
Omicron Pushes Health Authorities Toward Learning to Live With Covid-19Health authorities are offering a glimpse into the future as they abandon restrictive steps designed to contain the virus and focus on hospitalized patients.
Lire la suite »
Omicron amps up concerns about long COVID and its causesMore than a year after a bout with COVID-19, Rebekah Hogan still suffers from severe brain fog, pain and fatigue that leave her unable to do her nursing job or handle household activities. Long COVID has her questioning her worth as a wife and mother.
Lire la suite »
COVID antiviral pills work against Omicron—when people can get themThree lab experiments show that Pfizer's COVID-19 pill, Paxlovid, holds up well against the Omicron variant, but supplies are limited.
Lire la suite »